September 26, 2012

Alliance Boots today has published its Corporate Social Responsibility (CSR) Report 2011/12 for the year ended 31 March 2012.

As a healthcare company, CSR is integral to Alliance Boots business, inherent in its values and forms a natural part of its culture. Working every day to contribute positively to the communities the Group serves, long-term partnerships continue to play a pivotal role in its CSR agenda.

In June 2011, Alliance Boots announced the roll-out of a pan-European partnership with the European Organisation for Research and Treatment of Cancer (EORTC) Charitable Trust, through which it has committed to raise €5 million by 2016 to establish a ‘Biobank’ for the study and development of cancer treatments.

In addition, the Group takes a holistic approach in its support in the fight against cancer; from helping people affected by the disease through its ongoing collaboration between Macmillan Cancer Support and Boots UK; to working to find new ways to fight and treat cancer through the Group’s partnership with the EORTC. This approach means that Alliance Boots is supporting the fight against cancer on all levels: in diagnosis, treatment and support.

On the environment, Alliance Boots is determined to be a leader and an example to others in addressing climate change. The Group pursues many practical activities that contribute to the overall reduction of its carbon footprint. Additionally, the Group encourages waste reduction and an increase in recycling, and during 2011/12, 12 of the Group's principal businesses now recycle 50% or more of their waste.

As part of its CSR programme, Alliance Boots has a ‘champion’ in most of its businesses with responsibility for defining and delivering local CSR priorities and targets in line with the Group’s overall objectives. The teams across the Group are at heart of this commitment and have embraced initiatives and activities with enthusiasm.

Ornella Barra, Chairman of the social responsibilities committee for Alliance Boots, comments: “Corporate social responsibility forms a natural part of our Group’s business culture. Built on strong values with a deep commitment to making a difference, we strive to be a Group that our people, our customers and the communities we serve can be proud of. The engagement of our teams in supporting our CSR agenda is truly inspiring and our successes to date could not have been possible without their determined efforts.”

This year, Alliance Boots has also taken further strides to develop and improve its CSR reporting. The Report’s CSR data is independently assured by KPMG and the Group has also included a critical commentary on CSR report from Tomorrow’s Company. The report has been compiled using the Global Reporting Initiative (GRI) G3 Sustainability Reporting Guidelines and cover the substantive issues relevant to the Group.

The online report makes the most of the web’s flexibility, allowing readers to explore case studies, performance data, policies and to learn more about Alliance Boots partnerships.

The report can be accessed online here:


About Alliance Boots
Alliance Boots is a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Working in close partnership with manufacturers and pharmacists, we are committed to improving health in the local communities we serve and helping our customers and patients to look and feel their best. Our focus is on growing our two core businesses: pharmacy-led health and beauty retailing and pharmaceutical wholesaling and distribution.

Alliance Boots has a presence in more than 25* countries and employs over 116,000* people. Alliance Boots has pharmacy-led health and beauty retail businesses in 11* countries and operates more than 3,330* health and beauty retail stores, of which just over 3,200* have a pharmacy. In addition, Alliance Boots has around 625* optical practices, of which around 185* operate on a franchise basis. Our pharmaceutical wholesale businesses supply medicines, other healthcare products and related services to more than 170,000* pharmacies, doctors, health centres and hospitals from over 370* distribution centres in 21* countries.

* Figures are approximations as at 31 March 2012 and include associates and joint ventures.

About the EORTC
Founded in 1962, EORTC is the largest European clinical research organisation in the field of cancer, with a worldwide reputation. It is headquartered in Brussels and its network comprises over 300 hospitals in over 30 countries caring for around 180,000 patients. EORTC’s aim is to create Europe’s first ‘biobank’ for the study of cancer treatments, a unique scientific pan-European initiative, building on the mapping of the human genome.

For further information, please contact:

Group Communications, Alliance Boots
Yves Romestan / Laura Vergani / Katie Johnson / Julie Longton: Tel: +44 (0) 207 980 8585

RLM Finsbury
Katie Lang / Claire Scicluna: Tel: +44 (0) 207 251 3801

Full press release as PDF - 26 September 2012

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.